Serum/plasma homocysteine levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis

[1]  Douglas G. Altman,et al.  Analysing data and undertaking meta‐analyses , 2019, Cochrane Handbook for Systematic Reviews of Interventions.

[2]  Mh Megallaa,et al.  THU0282 Homocysteine: any role in peripheral vascular disease in systemic lupus erythematosus (SLE) patients? , 2017 .

[3]  A. Larsson,et al.  Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls , 2017, PloS one.

[4]  N. Khairy,et al.  Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases , 2017 .

[5]  E. Antiga,et al.  Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus. , 2016, Clinical and experimental rheumatology.

[6]  Z. Mo,et al.  Serum Homocysteine Concentration Is Significantly Associated with Inflammatory/Immune Factors , 2015, PloS one.

[7]  J. Sabio,et al.  Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus , 2015, Lupus.

[8]  J. Sabio,et al.  Relationship Between Homocysteine Levels and Hypertension in Systemic Lupus Erythematosus , 2014, Arthritis care & research.

[9]  A. Dyer,et al.  Risk Factors in the Progression of Subclinical Atherosclerosis in Women With Systemic Lupus Erythematosus , 2014, Arthritis care & research.

[10]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[11]  Xiaolan Huang,et al.  Hypomethylation of long interspersed nucleotide element‐1 in peripheral mononuclear cells of juvenile systemic lupus erythematosus patients in China , 2014, International journal of rheumatic diseases.

[12]  P. Tugwell,et al.  The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .

[13]  V. Kutala,et al.  Association of genetic variants of xenobiotic metabolic pathway with systemic lupus erythematosus. , 2013, Indian journal of biochemistry & biophysics.

[14]  V. D’Almeida,et al.  Dyslipidemia in Pediatric Systemic Lupus Erythematosus: The Relationship with Disease Activity and Plasma Homocysteine and Cysteine Concentrations , 2013, Annals of Nutrition and Metabolism.

[15]  B. Jallal,et al.  Biomarkers for systemic lupus erythematosus , 2012, International journal of rheumatic diseases.

[16]  S. Tyagi,et al.  Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. , 2011, Antioxidants & redox signaling.

[17]  P. Raggi,et al.  Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis , 2011, Arthritis care & research.

[18]  A. Stang Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[19]  S. Tyagi,et al.  Homocysteine to Hydrogen Sulfide or Hypertension , 2010, Cell Biochemistry and Biophysics.

[20]  Y. Shoenfeld,et al.  The geoepidemiology of systemic lupus erythematosus. , 2010, Autoimmunity reviews.

[21]  C. Lacabanne,et al.  Changes in the physical structure and chain dynamics of elastin network in homocysteine-cultured arteries. , 2009, Journal of biomedical materials research. Part A.

[22]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[23]  Jong Sun Park,et al.  Pulse wave velocity in young premenopausal women with systemic lupus erythematosus , 2009 .

[24]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.

[25]  A. Cucchiara,et al.  Functional Polymorphisms of Folate-Metabolizing Enzymes in Relation to Homocysteine Concentrations in Systemic Lupus Erythematosus , 2008, The Journal of Rheumatology.

[26]  Douglas G. Altman,et al.  Chapter 9: Analysing Data and Undertaking Meta-Analyses , 2008 .

[27]  A. Dyer,et al.  Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. , 2008, The Journal of rheumatology.

[28]  Michael H Weisman,et al.  New therapies for treatment of rheumatoid arthritis , 2007, The Lancet.

[29]  Xian Wang,et al.  Immunoregulatory effects of homocysteine on cardiovascular diseases. , 2007, Sheng li xue bao : [Acta physiologica Sinica].

[30]  P. Lazzerini,et al.  Hyperhomocysteinemia, inflammation and autoimmunity. , 2007, Autoimmunity reviews.

[31]  A. Whitehead,et al.  Monocyte chemoattractant protein-1: plasma concentrations and A(-2518)G promoter polymorphism of its gene in systemic lupus erythematosus. , 2007, The Journal of rheumatology.

[32]  J. Musial,et al.  [Antibodies to N-homocysteinylated albumin in patients with systemic lupus erythematosus]. , 2007, Polskie Archiwum Medycyny Wewnetrznej.

[33]  P. Raggi,et al.  High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors , 2006, Annals of the rheumatic diseases.

[34]  A. Akdoğan,et al.  Novel cardiovascular risk factors and cardiac event predictors in female inactive systemic lupus erythematosus patients , 2007, Clinical Rheumatology.

[35]  Chen-Kang Chang,et al.  Relationship of plasma interleukin-18 concentrations to traditional and non-traditional cardiovascular risk factors in patients with systemic lupus erythematosus. , 2006, Rheumatology.

[36]  R. Cron,et al.  Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[37]  T. Tso,et al.  Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus , 2006, Lupus.

[38]  A. Jenkins,et al.  Traditional risk factor assessment does not capture the extent of cardiovascular risk in systemic lupus erythematosus , 2006, Internal medicine journal.

[39]  Chen-Kang Chang,et al.  A positive correlation between homocysteine and brachial–ankle pulse wave velocity in patients with systemic lupus erythematosus , 2006, Clinical Rheumatology.

[40]  R. Kimberly,et al.  Genetics of susceptibility and severity in systemic lupus erythematosus , 2005, Current opinion in rheumatology.

[41]  S. Lentz Mechanisms of homocysteine‐induced atherothrombosis , 2005, Journal of thrombosis and haemostasis : JTH.

[42]  A. Amoroso,et al.  Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. , 2005, Arthritis and rheumatism.

[43]  C. Kallenberg,et al.  Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases , 2005, Annals of the New York Academy of Sciences.

[44]  Xiaofeng Li,et al.  [A clinical study of hyperhomocysteinemia in rheumatological diseases]. , 2005, Zhonghua nei ke za zhi.

[45]  B. Tsao Update on human systemic lupus erythematosus genetics , 2004, Current opinion in rheumatology.

[46]  Z. Amoura,et al.  Nucleosomes in the pathogenesis of systemic lupus erythematosus. , 2004, Rheumatic diseases clinics of North America.

[47]  P. Lipsky,et al.  Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. , 2004, Arthritis and rheumatism.

[48]  P. Lipsky,et al.  Biomarkers in systemic lupus erythematosus. I. General overview of biomarkers and their applicability. , 2004, Arthritis and rheumatism.

[49]  M. Alarcón‐Riquelme,et al.  The genetic basis of systemic lupus erythematosus--knowledge of today and thoughts for tomorrow. , 2004, Human molecular genetics.

[50]  D. Fuchs,et al.  Moderate hyperhomocysteinemia and immune activation. , 2004, Current pharmaceutical biotechnology.

[51]  I. Bruce,et al.  Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. , 2003, Arthritis and rheumatism.

[52]  E. Morand,et al.  Is macrophage migration inhibitory factor a therapeutic target in systemic lupus erythematosus? , 2003, Immunology and cell biology.

[53]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[54]  M. E. Arberas,et al.  Homocisteína plasmática en pacientes con lupus eritematoso sistémico , 2003 .

[55]  C. Cho,et al.  Acquired activated protein C resistance, high tissue factor expression, and hyper‐homocysteinemia in systemic lupus erythematosus , 2003, American journal of hematology.

[56]  G. Ruiz-Irastorza,et al.  [Plasma homocysteine levels in systemic lupus erythematosus]. , 2003, Medicina clinica.

[57]  A. Hamsten,et al.  Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease , 2002, Lupus.

[58]  T. Refai,et al.  Hyperhomocysteinaemia and Risk of Thrombosis in Systemic Lupus Erythematosus Patients , 2002, Clinical Rheumatology.

[59]  C. Woo,et al.  Increased Monocyte Adhesion to Aortic Endothelium in Rats With Hyperhomocysteinemia: Role of Chemokine and Adhesion Molecules , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[60]  J. Harley,et al.  The genetics of systemic lupus erythematosus: putting the pieces together , 2002, Genes and Immunity.

[61]  B. Richardson,et al.  Pathogenesis of lupus. , 2002, Arthritis and rheumatism.

[62]  T. Cheng,et al.  Elevated Homocysteine Levels in Patients with Raynaud’s Phenomenon Secondary to Systemic Lupus Erythematosus , 2002, Clinical Rheumatology.

[63]  M. Meydani,et al.  Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. , 2002, Atherosclerosis.

[64]  A. Hamsten,et al.  Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus , 2001, Circulation.

[65]  T. Behrens,et al.  Delineating the genetic basis of systemic lupus erythematosus. , 2001, Immunity.

[66]  N. Sivasubramanian,et al.  Homocysteine Induces Expression and Secretion of Monocyte Chemoattractant Protein-1 and Interleukin-8 in Human Aortic Endothelial Cells: Implications for Vascular Disease , 2001, Circulation.

[67]  K. Ihara,et al.  Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. , 2001, Rheumatology.

[68]  L. Criswell,et al.  The Fcgamma receptor IIIA-158F allele is a major risk factor for the development of lupus nephritis among Caucasians but not non-Caucasians. , 2001, Arthritis and rheumatism.

[69]  W. Arend,et al.  Physiology of cytokine pathways in rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[70]  M. Mamula,et al.  Molecular mimicry and the role of B lymphocytes in the processing of autoantigens , 2000, Cellular and Molecular Life Sciences CMLS.

[71]  E. Martı́n-Mola,et al.  Increased plasma levels of homocysteine and other thiol compounds in rheumatoid arthritis women. , 1999, Clinical biochemistry.

[72]  H. Blom,et al.  Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis , 1999, Annals of the rheumatic diseases.

[73]  P. D. de Groot,et al.  Homocysteine, methylenetetrahydrofolate reductase polymorphism, antiphospholipid antibodies, and thromboembolic events in systemic lupus erythematosus: a retrospective cohort study. , 1998, The Journal of rheumatology.

[74]  J. Loscalzo,et al.  Homocysteine and atherothrombosis. , 1998, The New England journal of medicine.

[75]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[76]  R. Schlegel,et al.  Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[77]  B. Hultberg,et al.  Plasma homocysteine in renal failure. , 1993, Clinical nephrology.

[78]  W. Vermaak,et al.  Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. , 1993, The American journal of clinical nutrition.

[79]  J. Hardin The lupus autoantigens and the pathogenesis of systemic lupus erythematosus. , 1986, Arthritis and rheumatism.